New Results

The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, Henri Estanbouli, Aurélie Bouteau, Botond Z. Igyártó
doi: https://doi.org/10.1101/2021.03.04.430128

Article usage

Article usage: March 2021 to June 2022

AbstractFullPdf
Mar 20214047709905
Apr 20212320848382
May 202172221456790
Jun 2021539227922228
Jul 2021319022681065
Aug 202134701879711
Sep 20212835779567
Oct 20212345807510
Nov 20212182499558
Dec 202126441784684
Jan 202219551215505
Feb 2022904490247
Mar 2022679336222
Apr 2022644205188
May 2022584179192
Jun 2022490165148
Back to top
Posted March 04, 2021.
Download PDF

Supplementary Material

Email
The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, Henri Estanbouli, Aurélie Bouteau, Botond Z. Igyártó
bioRxiv 2021.03.04.430128; doi: https://doi.org/10.1101/2021.03.04.430128
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area